Condylomata Acuminata
Showing 1 - 25 of 92
Condylomata Acuminata Trial in Herne (Carbon dioxide Laser ablation, Electrocoagulation)
Recruiting
- Condylomata Acuminata
- Carbon dioxide Laser ablation
- Electrocoagulation
-
Herne, NRW, GermanyDepartment of Obstetrics and Gynecology of the Ruhr University B
Jan 24, 2023
Human Papilloma Virus, Warts, Warts, Genital Trial in San Francisco (nonavalent human papillomavirus vaccine)
Recruiting
- Human Papilloma Virus
- +4 more
- nonavalent human papillomavirus vaccine
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
May 20, 2022
Human Papilloma Virus, Anogenital Wart Trial in Zagazig (the Quadrivalent Vaccine (Gardasil))
Recruiting
- Human Papilloma Virus
- Anogenital Wart
- the Quadrivalent Vaccine (Gardasil)
-
Zagazig, EgyptRana Ehab
Feb 26, 2023
Papillomavirus Infections, Warts, Condylomata Acuminata Trial in Akron (PURELL VF481, Placebo Solution)
Completed
- Papillomavirus Infections
- +3 more
- PURELL VF481
- Placebo Solution
-
Akron, OhioAkron Dermatology
Jan 3, 2023
Condylomata Acuminata Trial in San Antonio (East Indian Sandalwood Oil Cream)
Terminated
- Condylomata Acuminata
- East Indian Sandalwood Oil Cream
-
San Antonio, TexasProgressive Clinical Research
Apr 27, 2021
Anogenital Wart Trial in Makassar (Topical Ethanol Extract (Piper crocatum), Trichloroacetic Acid Topical)
Not yet recruiting
- Anogenital Wart
- Topical Ethanol Extract (Piper crocatum)
- Trichloroacetic Acid Topical
-
Makassar, South Sulawesi, IndonesiaWahidin Sudirohusodo General Hospital
Nov 14, 2022
Cervical Cancer, Genital Wart, CIN Trial in Nanning (Zerun HPV-9, GARDASIL ®9)
Active, not recruiting
- Cervical Cancer
- +4 more
- Zerun HPV-9
- GARDASIL ®9
-
Nanning, Guangxi, ChinaGuangXi Center for Diseases Control and Prevention
Oct 26, 2022
After Whole Vaccination Shcedule With Recombination Quadrivalent
Not yet recruiting
- HPV Infections
- +6 more
- (no location specified)
May 7, 2022
Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine
Not yet recruiting
- Cervical Cancer
- +11 more
- Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
- Placebo
- (no location specified)
Oct 17, 2022
Condylomata Acuminata Trial (low dosage HPV Vaccine, medium dosage HPV Vaccine, high dosage HPV Vaccine)
Completed
- Condylomata Acuminata
- low dosage HPV Vaccine
- +3 more
- (no location specified)
May 23, 2022
Perianal Warts Trial in San Diego, San Francisco (Leukocyte Interleukin, Injection)
Terminated
- Perianal Warts
- Leukocyte Interleukin, Injection
-
San Diego, California
- +1 more
May 8, 2022
Interleukin 4 and Interferon Gamma Predictors of Human
Completed
- Warts Hand
- Wart, Genital
- IL-4 and IFN-γ measurements
-
Zagazig, Sharkia, EgyptZagazig University Faculty of Medicine
Oct 28, 2021
Cervical Cancer, Genital Warts Trial (Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine, Matching Placebo)
Active, not recruiting
- Cervical Cancer
- Genital Warts
- Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine
- Matching Placebo
- (no location specified)
Aug 22, 2022
Genital Warts Trial in Guang'an, Mianyang (9vHPV vaccine)
Recruiting
- Genital Warts
- 9vHPV vaccine
-
Guang'an, Sichuan, China
- +1 more
May 11, 2022
Condylomata Acuminata Trial (low dosage HPV Vaccine(1:1), low dosage HPV Vaccine(1:2), high dosage HPV Vaccine(1:1))
Active, not recruiting
- Condylomata Acuminata
- low dosage HPV Vaccine(1:1)
- +3 more
- (no location specified)
Feb 10, 2022
Condylomata Acuminata, Papillomavirus Infections, Skin Diseases, Viral Trial in United States (VP-102 and applicator, Placebo)
Completed
- Condylomata Acuminata
- +7 more
- VP-102 and applicator
- Placebo
-
Plainfield, Indiana
- +3 more
Aug 27, 2021
Human Papillomavirus Infection, Anogenital Warts Trial in Moscow (Interferon gamma human recombinant (IFN-G))
Completed
- Human Papillomavirus Infection
- Anogenital Warts
- Interferon gamma human recombinant (IFN-G)
-
Moscow, Russian FederationState scientific center of a dermatovenereology and cosmetology
Nov 30, 2021
HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)
Recruiting
- HPV Infections
- +14 more
- 9-valent HPV vaccine
-
Hangzhou, ChinaHuakun Lv
Feb 23, 2022
HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus
Completed
- HPV Infections
- +14 more
- Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Active Comparator: GARDASIL ®9
-
Guangxi, ChinaGuangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022
HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among
Recruiting
- HPV Infections
- +6 more
- 2-doses Group among 9-14 years
- +2 more
-
Mianyang, Sichuan, ChinaCenter for Disease Control and Prevention
Feb 23, 2022
Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)
Completed
- Cervical Cancer
- +13 more
- 4-valent HPV Vaccine
- +2 more
-
Yangchun, Guangdong, ChinaYangchun Center For Disease Prevention And Control
Feb 23, 2022
Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,
Recruiting
- Cervical Cancer
- +13 more
- 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
- GARDASIL®
-
Rongan County, Guangxi Zhuang Autonomous Region, ChinaRongan County Center for Disease Control and Prevention
Feb 20, 2022
Cervical Cancer, Condylomata Acuminata Trial in Nanjing (Recombinant Human Papillomavirus Nonavalent (Types
Active, not recruiting
- Cervical Cancer
- Condylomata Acuminata
- Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
- Gardasil®9
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Centre for Disease Control and Prevention
Feb 10, 2022
Cervical Intraepithelial Neoplasia, Cervical Cancer, Condylomata Acuminata Trial in Nanjing, Chengdu (Nonavalent HPV vaccine,
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- +2 more
- Nonavalent HPV vaccine
- Bivalent HPV vaccine
-
Nanjing, Jiangsu, China
- +1 more
Feb 10, 2022
Genital Wart and Sexuality in Adolescence
Completed
- Adolescent Development
- +3 more
- Clinical assessment
-
Ankara, TurkeyAnkara City Hospital
Mar 11, 2021